OVERVIEW

6th Miami Thyroid Oncology Annual Symposium is organized by Miami Cancer Research Center (MCRC) and will be held from Oct 27 - 28, 2023.

Description:
We welcome you to the 6th Miami Thyroid Oncology Symposium to discuss the rapidly expanding science of "Thyroid Oncology". A broad catalog of genomic and epigenomic markers has been identified and integrated into the cytologic and pathologic evaluation of nodular thyroid disease and thyroid cancer. Risk stratification systems that are critical for initial surgical treatment and subsequent use of radioactive iodine treatment rely more on distinct molecular markers involving theranostic considerations. The traditional characterization of tumor differentiation/de-differentiation for the purposes of clinical prognostic assessments and more importantly definition/redefinition of the role of RAI treatment for individual cancer phenotypes are now being expressed by molecular characteristics.

The symposium is a two-day program. The first day of the symposium on Friday, October 27th, 2023, where we will highlight Frontiers in Thyroid Oncology. This session brings together world-renowned experts presenting and discussing the state of the art in thyroid cancer diagnosis and treatment. The second day of the symposium on Saturday, October 28th, 2023, will feature a workshop on Advances in Radioactive Iodine (RAI) Theranostics, which will provide an in-depth overview of RAI theranostics and address current controversies on RAI imaging, ablation, and approaches for RAI-indifferent cancers.

The 2023 Miami Thyroid Oncology Symposium (MTOS) will be held in a hybrid format. The core faculty will gather at the MTOS conference center and jointly run sessions with the participation of international guest faculty and symposium registrants. The sessions will involve brief formal presentations, case discussions, panel debates, and Q&A. Technical topics will include video presentations as well.

We are committed to upholding the high-quality symposium standards we have built in the prior years. We are indebted to our world-renowned faculty for taking part in this exciting new scientific platform. We also hope to expand our attendance by reaching a larger national and international audience through the hybrid format.